We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Vacuum Blood Collection Tube Market Driven by Increasing Infectious Diseases

By LabMedica International staff writers
Posted on 27 Sep 2023

The vacuum blood collection tube market is expanding significantly because these tubes are crucial for diagnosing various medical issues, from infections and anemia to more serious conditions like leukemia and kidney dysfunction. More...

These tubes are indispensable for laboratory tests, helping healthcare providers to start treatments for different illnesses in a timely manner. In comparison to the conventional methods of drawing blood with syringes, vacuum tubes offer multiple benefits. They provide a safer experience for those drawing the blood and ensure cleaner samples because there's less handling and transferring. These tubes are also simpler to use and contain pre-mixed additives. The tubes come with color-coded caps, making it easier for healthcare professionals to understand and communicate about the tests needed. Additionally, they allow for multiple samples to be taken at once, which lowers the chances of damaging the blood cells or hemolysis. Using these vacuum tubes, or "vacutainers," improves the efficiency of diagnostic procedures, shortens the time needed to collect blood samples, and reduces the potential for injuries from needles as well as the risk of sample contamination.

The global vacuum blood collection tube market is projected to register a Compound Annual Growth Rate (CAGR) of 3.02% during the forecast period 2023 – 2030 to reach USD 3.20 billion by the year 2030. Several factors are driving the market's growth, including the rising prevalence of chronic and infectious diseases, and the growing incidence of hematological disorders. In addition, the emergence and re-emergence of infectious diseases pose a significant public health threat, driving the demand for blood collection tubes for clinical diagnostics. The demand for blood collection tubes for clinical diagnostics is expected to increase on account of frequent disease outbreaks in endemic regions. The increase in blood donations is also expected to result in an increase in the usage of blood collection tubes, thereby fueling market growth. However, the vacuum blood collection tube market is plagued by certain challenges, such as a shortage of skilled personnel and low awareness of products in low- and middle-income regions.

These are the latest findings of Research and Markets (Dublin, Ireland), a source for international market research reports.

Based on type, the serum-separating tube segment held the largest share of the vacuum blood collection tube market in 2022, mainly due to the benefits of the barrier gel, which allows for rapid separation of serum from cellular components in blood, thereby reducing hemolysis. By material, the PET/plastic material segment dominated the vacuum blood collection tube market in 2022 due to its advantages over glass, including lower exposure to biohazardous material following breakage, tolerance of higher centrifugation speeds, greater shock resistance, lighter weight, and simpler disposal using cost-effective incineration.

Based on application, the blood routine examination segment held the largest share of the vacuum blood collection tube market in 2022, driven by the prevalence of lifestyle diseases and growing awareness of routine medical examinations. By end-user, pathology laboratories dominated the vacuum blood collection tube market in 2022, led by the high prevalence of diseases such as hepatitis B, HIV AIDS, diabetes, cancer, and heart diseases, which require different types of blood tests to gauge disease severity. Geographically, North America dominated the global vacuum blood collection tube market in 2022, due to the presence of leading clinical diagnostics companies, well-developed healthcare infrastructure, and higher R&D activities in the region.

Related Links:
Research and Markets 


New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
New
Blood Glucose Test Strip
AutoSense Test
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AiPlex VAS for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with autoimmune vasculitis (Photo courtesy of AliveDx)

Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis

Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.